The effect of inhibition of prostaglandin F2 alpha synthesis on placental expulsion in the ewe.
Five ewes were injected with two doses of a nonsteroidal anti-inflammatory drug (NSAI), lysine acetyl salicylate, at birth of their first lamb and one hour later, and five others were injected once only, at birth of their first lamb. A control group of six animals was constituted. The times needed for fetal expulsion and placental release were recorded. The peripheral plasma PgF2 alpha (as PGFM) levels were measured prepartum during the seven last days of gestation, at parturition, then 1 h, 2 h and 12 h after lambing. The results were compared among and within treatment groups. They indicate that the physiological increase in peripheral PGFM levels starts two days before lambing and that the level peaks at lambing. The normal decrease after parturition is emphasized by NSAI injections as detected 1 h and 2 h posttreatment (p < 0.01). The NSAI drug is short-acting as revealed by the lower PGFM levels in twice-treated animals 2 h after birth compared to once treated animals and the similar low levels in all three groups 12 h after birth. The fetal membranes were expelled normally in all treated and nontreated animals, but the time needed for placental expulsion in ewes injected with two doses of NSAI was longer than in controls (p < 0.05). A negative correlation (p < 0.05) was found between plasma PGFM levels measured two hours after lambing and the time needed for fetal membrane expulsion. PgF2 alpha appears to have a role in placental release in the ewe.
Laboratoire d'Ecopathologie, Centre de Recherches de Clermont-Ferrand-Theix, Saint-Genès-Champanelle, France.
M
M
Chassagne
J
J
Barnouin
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology; D001241:Aspirin / Q000031:analogs & derivatives / Q000494:pharmacology; D015237:Dinoprost / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000097:blood / Q000502:physiology*; D005260:Female; D007743:Labor, Obstetric / Q000097:blood / Q000187:drug effects / Q000502:physiology*; D008239:Lysine / Q000031:analogs & derivatives / Q000494:pharmacology; D008297:Male; D010920:Placenta / Q000187:drug effects / Q000502:physiology*; D011247:Pregnancy; D012756:Sheep / Q000097:blood / Q000502:physiology*; D013997:Time Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; C008228:15-keto-13,14-dihydroprostaglandin F2alpha; D015237:Dinoprost; D008239:Lysine; D001241:Aspirin; C010395:acetylsalicylic acid lysinate